Clinical Trial Update: Intramuscular Mononuclear Cells and Mesenchymal Stem Cells Transplantation to Treat Chronic Critical Limb Ischemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intramuscular autologous mononuclear cells and mesenchymal stem cell transplantation for chronic critical limb ischemia, sponsored by t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• Autologous mononuclear cell transplantation
• Mesenchymal stem cell transplantation (mesenchymal stem cells)

Snippet

Sponsor: National University of Malaysia | Conditions: Critical Limb Ischemia | Phase 2 | Status: UNKNOWN